Frontiers in Psychiatry | Psychopharmacology

Editorial

Published on 18 Oct 2022

Editorial: Advances in therapeutic drug monitoring of psychiatric subjects: Analytical strategies and clinical approaches

in Psychopharmacology

Laura Mercolini

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1056380

1,711 views
3 citations

Systematic Review

Published on 17 Oct 2022

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy

in Psychopharmacology

Luzie Eichentopf
Christoph Hiemke
Andreas Conca
Jan Engelmann
Manfred Gerlach
Ursula Havemann-Reinecke
Gudrun Hefner
Vincenzo Florio
Maxim Kuzin
Klaus Lieb

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.972141

8,156 views
11 citations

Mini Review

Published on 12 Oct 2022

Parvalbumin and parvalbumin chandelier interneurons in autism and other psychiatric disorders

in Psychopharmacology

Pablo Juarez
Verónica Martínez Cerdeño

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.913550

7,106 views
29 citations

Review

Published on 12 Oct 2022

A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy

in Psychopharmacology

Robert J. Sottile
Thomas Vida

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.991753

17,661 views
14 citations

Perspective

Published on 11 Oct 2022

A methodological note on the CYP-guides randomized controlled trial for the treatment of major depression

in Psychopharmacology

Georgios Sideridis
Ghadah Alkhadim

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.888065

999 views

Original Research

Published on 10 Oct 2022

MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials

in Psychopharmacology

Christopher S. Stauffer
Melanie R. Brown
Dee Adams
Marca Cassity
Jae Sevelius

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.932605

11,003 views
15 citations

Review

Published on 03 Oct 2022

3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs

in Psychopharmacology

Raúl López-Arnau
Jordi Camarasa
Marcel·lí Carbó
Núria Nadal-Gratacós
Pol Puigseslloses
María Espinosa-Velasco
Edurne Urquizu
Elena Escubedo
David Pubill

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.990405

8,394 views
6 citations

Perspective

Published on 29 Sep 2022

Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management

in Psychopharmacology

Ryan Yip
Jennifer Swainson
Atul Khullar
Roger S. McIntyre
Kevin Skoblenick

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1017504

14,861 views
8 citations

Original Research

Published on 28 Sep 2022

Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs

in Psychopharmacology

Eric Sparkes
Rochelle Boyd
Shuli Chen
Jack W. Markham
Jia Lin Luo
Tahira Foyzun
Humayra Zaman
Charlotte Fletcher
Ross Ellison
Iain S. McGregor

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1010501

8,430 views
9 citations

Brief Research Report

Published on 28 Sep 2022

Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use

in Psychopharmacology

Kazi Hassan
William M. Struthers
Aditya Sankarabhotla
Patrick Davis

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.992624

37,257 views
15 citations

Editorial

Published on 28 Sep 2022

Editorial: Novel antipsychotics within and beyond clinical trials: The treatment of overlapping psychiatric disorders with D3-D2 partial agonists

in Psychopharmacology

György Németh
Réka Csehi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.1038627

1,629 views
4 citations

Original Research

Published on 27 Sep 2022

Facing death, returning to life: A qualitative analysis of MDMA-assisted therapy for anxiety associated with life-threatening illness

in Psychopharmacology

William Barone
Michiko Mitsunaga-Whitten
Lia Osunfunláyò Blaustein
Phillip Perl
Marisa Swank
Thomas Cody Swift

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.944849

10,783 views
7 citations

Systematic Review

Published on 26 Sep 2022

Effects of synthetic cannabinoids on psychomotor, sensory and cognitive functions relevant for safe driving

in Psychopharmacology

Vasco Orazietti
Giuseppe Basile
Raffaele Giorgetti
Arianna Giorgetti

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.998828

3,035 views
11 citations

Hypothesis and Theory

Published on 20 Sep 2022

Knowing and being known: Psychedelic–assisted psychotherapy and the sense of authenticity

in Psychopharmacology

Lawrence G. Fischman

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.933495

6,764 views
4 citations

Original Research

Published on 16 Sep 2022

Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression

in Psychopharmacology

Wei Zheng
Xin-Hu Yang
Li-Mei Gu
Jian-Qiang Tan
Yan-Ling Zhou
Cheng-Yu Wang
Yu-Ping Ning

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.981981

2,167 views
5 citations

Case Report

Published on 16 Sep 2022

Schizophrenia treatment with a combination of two LAI antipsychotics: A case report

in Psychopharmacology

Marcin Jarosz
Karina Badura-Brzoza

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.975531

5,149 views
2 citations